Search Results

Canada's Federal Budget Earmarks Dedicated Funding to Advance Nuclear Energy Strategy

Recently, the Government of Canada officially released the 2026 federal budget, committing more than CAD 518.5 million (approximately EUR 329 million, USD 536 million) to the national nuclear energy strategy, establishing nuclear technology as a core cornerstone for achieving the nationwide clean electricity plan. Under the leadership of Prime Minister Mark Carney, Canada is committed to consolidating its position as a global clean energy superpower through comprehensive support for reactor deployment and supply chain development. This newly announced nuclear development plan builds upon the national nuclear energy strategy released by the government in June this year and is part of the overall capital expenditure of up to CAD 8 billion for electricity-related projects over the next five years...

2026-11-07

US Company Publishes Long-Term Safety Study of Targeted Radiopharmaceutical for Leukemia

Recently, a new American Society of Hematology (ASH) conference abstract has been developed from the long-term safety and tolerability study of Actimab-A combined with CLAG-M intensive salvage chemotherapy, focusing on the recovery of patients with relapsed or refractory acute myeloid leukemia after treatment. This progress extends the research focus from prior antitumor activity to long-term follow-up, supplementing data for continued development of the combination regimen. Actimab-A is an investigational targeted α therapy developed by Actinium Pharmaceuticals, composed of the antibody lintuzumab conjugated with actinium-225. This abstract involves follow-up of patients in a Phase I study who survived at least three months after treatment, with emphasis on analyzing blood cell count recovery and potential delayed renal and hepatic toxicity, in order to more comprehensively evaluate the safety profile after intensive treatment.

2026-11-05

Australian Company Finalizes Phase III Protocol for Brain Metastasis Imaging Radiopharmaceutical

Recently, Radiopharm Theranostics announced that it has received the final meeting minutes from the FDA End-of-Phase 2 meeting, during which both parties reached agreement on the design of the pivotal Phase III imaging trial for RAD101, advancing registration development preparations for this investigational radiopharmaceutical imaging agent. The study is planned as a single-arm, multicenter Phase III trial designed to enroll approximately 280 patients with previously irradiated brain metastases of indeterminate nature. The co-primary endpoints are the sensitivity and specificity of RAD101 PET relative to an established reference standard. RAD101 is labeled with Fluorine-18, and its development goal is to help identify brain metastasis lesions and improve the differentiation between tumor recurrence and treatment-related changes. Si...

2026-11-04

CNNC Atom High-Tech Sodium Iodide Capsules Supplied Directly to Macao for the First Time

Recently, sodium iodide [¹³¹I] capsules independently developed and produced by Atom High-Tech Co., Ltd., a subsidiary of China Isotope & Radiation Corporation under CNNC, successfully arrived at clinical frontlines in Macao, achieving the first stable supply of domestically produced sodium iodide [¹³¹I] capsules to Macao and completely filling the previous gap in Macao's lack of this clinical diagnostic and therapeutic service. It is understood that sodium iodide [¹³¹I] capsules are core radiopharmaceuticals widely used clinically for the diagnosis and treatment of thyroid diseases. Previously, Atom High-Tech had successfully achieved routine supply of short-half-life radiopharmaceuticals to Macao; the successful launch of this new product will strongly support Macao medical institutions in carrying out systematic radionuclide therapy and effectively reduce the burden of cross-border medical treatment on local patients.

2026-11-02

CNNC Hosts the 6th Radiopharmaceutical and Radionuclide Production Worker Vocational Skills Competition, Leveraging Shared Laboratories to Deepen Skilled Talent Cultivation

The 2026 6th CNNC Radiopharmaceutical and Radionuclide Production Worker Vocational Skills Competition, themed "Forging Craftsmanship with Nuclear Power, Winning the Future with Skills," was successfully held from October 20 to 24 at the Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment. The competition was hosted by CNNC and organized by China Isotope & Radiation Corporation, and is a key practical measure for CNNC and the Nuclear and Radiation Safety Center to deepen strategic coordination and advance the construction of shared laboratories. The two sides closely focused on research directions including radiation environmental monitoring, nuclide analysis, and precise sample testing, promoting the co-construction and sharing of instruments and equipment, reference materials, methodology systems, and data platforms. A total of 16 units and 3...

2026-10-25

CGN Biodiversity Protection Case Selected for Report of the 17th Conference of the Parties to the United Nations Convention on Biological Diversity: Daya Bay Base Demonstrates Harmonious Coexistence of Nuclear Power and Marine Ecology

At the China Pavilion event of the 17th Conference of the Parties to the United Nations Convention on Biological Diversity, the Ministry of Ecology and Environment of China officially released the "Beauty of Diversity: Nature-Positive Solutions Report of Chinese Enterprises." The typical case submitted by China General Nuclear Power Group (CGN), "Advancing Habitat Protection to the Decision-Making Stage of Clean Energy Development," was successfully selected, systematically presenting on the international multilateral stage the innovative governance achievements of Chinese energy enterprises in coordinating zero-carbon electricity supply with ecological habitat restoration. According to the practical experience disclosed in the report, CGN deeply integrates the concept of nature conservation into the entire lifecycle of corporate investment decisions and production operations, strictly aligning with Targets 1...

2026-10-25

Armenia and the United States discussed the construction of a new nuclear power unit project

As the Armenian government evaluates international options to replace the aging Metsamor Nuclear Power Plant, Armenia and the United States discussed the construction of a new nuclear power unit project. Narek Apitonyan, Deputy Minister of the Ministry of Territorial Administration and Infrastructure of Armenia, met in Yerevan with a U.S. delegation led by Shauna Wilson, Deputy Assistant Secretary of State for Security Assistance. The two sides reviewed existing bilateral energy cooperation projects and exchanged views on prospects for expanding cooperation. According to the Ministry of Territorial Administration and...

2026-10-24

Southwest Supervision Station of the National Nuclear Safety Administration Conducts Demonstrative Supervision of Radiopharmaceuticals

Recently, the Southwest Nuclear and Radiation Safety Supervision Station of the Ministry of Ecology and Environment (National Nuclear Safety Administration), together with the Department of Radiation Source Safety Supervision, the Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment, and Chengdu University of Technology, organized representatives of enterprises in its jurisdiction to conduct demonstrative supervision of radiopharmaceutical (medical isotope) production. This initiative aims to serve the national "Medium- and Long-Term Development Plan for Medical Isotopes (2021–2035)" and comprehensively enhance the radiation safety management level of the nuclear medical industry in the Southwest region. It is reported that this supervision activity practiced the concept of research-based supervision. In response to the characteristics of the Southwest region—where R&D, pilot testing, and large-scale production proceed in parallel, and the safety risks of unsealed radioactive materials are complex—the activity involved pre-arranging production processes...

2026-10-22

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds Held in Chongqing, Focusing on Alpha Nuclide Targeting and Theranostics

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds was held on October 10-11 at the Chongqing Science Hall. The conference was co-hosted by the China Isotope & Radiation Corporation Research Institute and the IAEA Collaborating Centre for Radiopharmaceuticals and Radioactive Sources, co-organized by the Nuclear Medicine Branch of the Chinese Medical Association, the Isotope Branch of the Chinese Nuclear Society, the Radiopharmaceuticals Branch of the Chinese Nuclear Society, and the Nuclear Chemistry and Radiochemistry Branch of the Chinese Nuclear Society, and undertaken by China Isotope & Radiation Corporation and the Chongqing Nuclear Society. More than 400 experts, scholars, clinicians and...

2026-10-12

GE HealthCare Plans $945 Million All-Cash Acquisition of Sofie Biosciences: Full-Scale Positioning in the "Final Mile" Delivery of Positron Radiopharmaceuticals and CDMO Capacity

GE HealthCare, the Chicago-based medical imaging and radiodiagnostics giant, has announced that it has entered into a definitive acquisition agreement to acquire radiopharmaceutical company Sofie Biosciences in an all-cash deal valued at $945 million from private equity firm Trilantic North America. The transaction is expected to complete all regulatory approvals and closing procedures by July 2027, and is expected to be accretive to GE HealthCare's revenue growth and adjusted earnings in the first full fiscal year following closing. Founded in 2008 and headquartered in Dulles, Virginia, Sofie Biosciences has built a broad radiopharmaceutical production and distribution network across the United States...

2026-10-08

Armenia and Rosatom Coordinate the Second Life Extension of Metsamor NPP Unit 2: Reviewing Phase Results and Locking In Key Tasks for 2027–2030

On October 7, 2026, the fifth working meeting of the Joint Coordination Committee of the Republic of Armenia and Rosatom was held in Yerevan, comprehensively reviewing the phased implementation results of the major project for the second life extension (LTO-2) of Unit 2 of the Armenian NPP (ANPP, located in Metsamor), and formally countersigned the execution agreement for advancing engineering tasks from 2027 to 2030. Kirill Komarov, First Deputy Director General and Director for International Business Development of Rosatom, led the Russian delegation, while Narek Apitonyan, Deputy Minister of Territorial Administration and Infrastructure of Armenia, led the Armenian delegation.

2026-10-08

Rosatom Proposes New VVER-1000 Nuclear Power Unit to Armenia

Alexey Likhachev, Director General of Rosatom, recently stated in Yerevan that the company has submitted specific proposals to the Armenian government for the construction of a gigawatt-class VVER-1000 nuclear power unit. The proposal is based on an assessment of Armenia's electricity demand through 2040 and plans to adopt Russia's mature pressurized water reactor technology, the VVER-1000, which features Generation 3+ safety systems and competitive electricity pricing advantages, and has already been built and commissioned in Russia, India, Iran, and other countries. The Russian side calls this option the optimal choice for the international market and is willing to develop the project into a comprehensive cooperation project attracting international suppliers. Previously, Likhachev held talks with Armenian Prime Minister Nikol Pashinyan and...

2026-10-03

New Generation "Harmony System" and Other Technological Achievements Debut at the 23rd China-ASEAN Expo

At the five-day 23rd China-ASEAN Expo and China-ASEAN Business and Investment Summit, CGN showcased its innovative achievements in nuclear power, new energy, and digitalization under the theme "Smart Nuclear Powers Free Trade, Green Electricity Connects ASEAN." At the exhibition, CGN Digital Technology highlighted its independently developed Harmony System series products and their applications in the new energy sector, and used virtual reality technology to give visitors the opportunity to tour nuclear power plants. The Harmony System is hailed as the "nerve center" and "brain" of nuclear power plants. It is China's independently developed nuclear safety-class digital instrumentation and control system, and has now been widely applied to 34 nuclear power units nationwide, covering second- to fourth-generation nuclear power reactor types and technologies. Through the comprehensive iterative upgrading of the Harmony System, CGN Digital Technology has equipped it with a smarter, safer, and more economical "super intelligent brain," aiming to provide digital and intelligent empowerment for the full-cycle production and operation of nuclear power plants.

2026-09-22

Armenia and the IAEA discuss the extension of the Metsamor Nuclear Power Plant and the selection of the reactor type for a new nuclear power plant

On September 15, Armenian Minister of Territorial Administration and Infrastructure David Khudatyan and International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi held talks in Vienna, during which the two sides held in-depth discussions on the progress of the life extension project for Unit 2 of the Armenian Nuclear Power Plant (ANPP) and the selection of the reactor type for a new nuclear power plant. According to a message posted by Khudatyan on social media, the talks were held during the 70th IAEA General Conference. We discussed with Rafael Grossi the ongoing and planned projects under the framework of industry cooperation with the IAEA...

2026-09-16

U.S. Army Deploys First Commercial Microreactor at Crane Base

The U.S. Army announced that it has ordered the first commercial microreactor for Naval Support Activity Crane in Indiana, marking a significant step in the United States' application of advanced nuclear energy technology. This micro-modular reactor (MMR), owned and operated by a commercial entity, will be installed at the base, becoming the U.S. Navy's first land-based advanced micro-modular reactor and Indiana's first power reactor. Naval Support Activity Crane is positioned by the U.S. Army as one of the leading centers in operational innovation and capability development. The deployment of the microreactor aims to provide reliable, 24-hour uninterrupted power, reducing dependence on the commercial power grid, thereby supporting critical missions in various...

2026-09-16